Found 5 matching trials
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1 PHASE1 PPI-668 is an antiviral agent (a hepatitis C NS5A inhibitor) that is being ...
Show More Location
Investigational site
Learn More & Join Trial
Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China PHASE1 The purpose of this study is to evaluate the Pharmacokinetics and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China PHASE1 The purpose of this study is to investigate the Pharmacokinetics and Safety...
Show More Location
The first hospital of Zhejiang province
Learn More & Join Trial
Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects. PHASE2 The purpose of this study is to assess the efficacy and safety of Ravidasvi...
Show More Location
Peking University People's hospital
Learn More & Join Trial
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C PHASE2 This study is designed to provide a preliminary assessment of the safety an...
Show More Location
Quest Clinical Research
Learn More & Join Trial